LEKSUM and SLU Partner to Pioneer Muscle Research in Unique ICU Lab

June 9th, 2025 4:00 AM
By: Newsworthy Staff

A groundbreaking partnership between LEKSUM and SLU establishes a unique muscle research lab, offering new hope for understanding and treating muscle myopathies in ICU patients.

LEKSUM and SLU Partner to Pioneer Muscle Research in Unique ICU Lab

The collaboration between LEKSUM LLC and the Swedish University of Agricultural Sciences (SLU) marks a significant advancement in muscle research, particularly for patients undergoing long-term mechanical ventilation in intensive care units (ICUs). This partnership facilitates the operation of a one-of-a-kind muscle research lab, led by Lars Larsson, MD/PhD, a renowned figure in muscle science. The lab's unique experimental ICU model overcomes the limitation of early mortality, enabling long-term studies crucial for understanding muscle mass and function loss under ICU conditions.

Traditional research models have been hampered by the inability to sustain life support beyond a few days, a critical barrier since it takes at least five days of ICU conditions to develop critical illness myopathy (CIM). This condition mirrors the plight of human ICU patients, making the lab's capability to replicate long-term survival a game-changer for both mechanistic and intervention studies. The implications of this research are profound, offering potential therapies for millions affected by muscle myopathies annually.

Professor Larsson's enthusiasm for the partnership underscores its potential to revolutionize the treatment of acquired muscle myopathies. The lab's work could lead to clinical approaches for both preventing and treating these conditions, addressing a significant unmet need in critical care medicine. The partnership not only advances scientific understanding but also paves the way for developing biologic therapies targeting muscle loss due to mechanical ventilation, immobilization, and other conditions like sarcopenia and cancer cachexia.

This initiative represents a critical step forward in addressing the challenges faced by ICU patients, with the potential to improve outcomes and quality of life for individuals worldwide. The collaboration between LEKSUM and SLU exemplifies how innovative research models can bridge gaps in medical science, offering hope where traditional methods have fallen short.

Source Statement

This news article relied primarily on a press release disributed by Reportable. You can read the source press release here,

blockchain registration record for the source press release.
;